When evaluating multiyear payment arrangements, it's important to assess retention rates for patients with rare diseases. This study found subscriber retention is high for adults diagnosed with a rare disease and excluding this assessment could lead to inaccurate expectations for health insurers and plan administrators.
This article was originally published by JMCP.
Article
The No Surprises Act requires plan sponsors to comply with some of the most burdensome tasks since the Affordable Care Act.
An analysis of member retention patterns for adult rare disease cohorts to support evaluating multiyear payment arrangements for novel therapies
Evaluating multiyear payment arrangements? Assess retention rates for patients with rare diseases.